GO:0100001 regulation of skeletal muscle contraction by action potential: Excitation-Contraction Coupling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0100001 describes how action potentials regulate skeletal muscle contraction, a process known as excitation-contraction coupling.
• The action potential triggers calcium release from the sarcoplasmic reticulum, which activates myosin-based contraction.
• Thick filament regulation by myosin-binding protein C and titin fine-tunes contraction strength and speed.
• Disruptions in this process contribute to muscle fatigue, myopathies, and electrolyte disorders.
• Key genes include RYR1, CACNA1S, ATP2A1, MYH7, and TNNT3, which are targets for CRISPR modeling.
• EDITGENE provides knockout, point-mutation, knock-in, and overexpression models to study these genes in skeletal muscle cells.
Description
The Gene Ontology term GO:0100001, regulation of skeletal muscle contraction by action potential, defines the biological process by which electrical signals (action potentials) control the mechanical contraction of skeletal muscle. This process is fundamental to movement, posture, and breathing, and its dysfunction underlies numerous muscle disorders. Understanding the molecular players and regulatory mechanisms is essential for researchers in muscle physiology, exercise science, and neuromuscular disease. Recent studies have elucidated how action potentials propagate along the sarcolemma and T-tubules to trigger calcium release, and how thick filament proteins modulate contraction. This article synthesizes current knowledge from authoritative sources to provide a research-grade overview of GO:0100001, its associated genes, and experimental approaches for its study.
regulation of skeletal muscle contraction by action potential At A Glance
| GO ID | GO:0100001 |
|---|---|
| GO term | regulation of skeletal muscle contraction by action potential |
| Ontology | biological_process |
| Synonym | none |
| Major function | Coupling electrical excitation to mechanical contraction in skeletal muscle |
| Key cellular components | Sarcolemma, T-tubules, sarcoplasmic reticulum, myofibrils |
| Key molecular players | Voltage-gated calcium channels, ryanodine receptors, SERCA, myosin, actin |
| Related processes | Excitation-contraction coupling, calcium signaling, muscle fatigue |
What Is GO:0100001?
GO:0100001 encompasses any action potential process that regulates skeletal muscle contraction. In practice, this includes the generation and propagation of action potentials in muscle fibers, their coupling to calcium release from the sarcoplasmic reticulum, and the subsequent activation of contractile proteins. The term captures the entire signaling cascade from membrane depolarization to mechanical force production, emphasizing the regulatory role of electrical excitability in muscle function.
Why Is regulation of skeletal muscle contraction by action potential Important in Cell Biology?
GO:0100001 is critical because it represents the primary mechanism by which the nervous system controls skeletal muscle force, influencing everything from voluntary movement to respiratory function. Defects in this process lead to conditions such as malignant hyperthermia, periodic paralyses, and age-related muscle weakness. Moreover, understanding this term aids in developing therapies for muscle wasting and metabolic disorders.
• Essential for voluntary movement and posture.
• Dysregulation causes muscle fatigue and reduced exercise performance.
• Mutations in RYR1 and CACNA1S lead to malignant hyperthermia and periodic paralysis.
• Implicated in electrolyte imbalances affecting muscle excitability.
• Target for anabolic interventions in muscle wasting.
• Key to understanding cardiac versus skeletal muscle differences.
• Provides insights into metabolic regulation during contraction.
• Facilitates development of gene therapies for myopathies.
What Happens During regulation of skeletal muscle contraction by action potential?
Action Potential Generation and Propagation
In simple terms: Nerve signals trigger an electrical impulse that travels along the muscle cell membrane.
Action potentials are initiated at the neuromuscular junction and propagate along the sarcolemma and into T-tubules. This depolarization is driven by voltage-gated sodium channels and is essential for subsequent calcium release.
Calcium Release from Sarcoplasmic Reticulum
In simple terms: The electrical signal opens calcium channels, releasing calcium stored inside the muscle cell.
Depolarization of T-tubules activates dihydropyridine receptors (DHPRs), which mechanically couple to ryanodine receptors (RYR1) on the sarcoplasmic reticulum, triggering calcium release. This calcium binds to troponin C, shifting tropomyosin to expose myosin-binding sites on actin.
Cross-Bridge Cycling and Force Generation
In simple terms: Calcium allows myosin to grab actin and pull, shortening the muscle.
Myosin heads bind to actin, forming cross-bridges that cycle in an ATP-dependent manner, generating force. The thick filament protein myosin-binding protein C modulates this process, affecting contraction speed and strength.
Calcium Reuptake and Relaxation
In simple terms: Calcium is pumped back into storage, allowing the muscle to relax.
SERCA pumps calcium back into the sarcoplasmic reticulum, reducing cytosolic calcium and terminating contraction. This reuptake is energetically costly and is tightly linked to ATP supply.
Key Genes Involved in GO:0100001 regulation of skeletal muscle contraction by action potential
The following genes encode proteins that are central to the regulation of skeletal muscle contraction by action potential.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RYR1 | Calcium release channel in sarcoplasmic reticulum | Mutations cause malignant hyperthermia and central core disease |
| CACNA1S | Voltage sensor in T-tubules (DHPR) | Linked to hypokalemic periodic paralysis |
| ATP2A1 | SERCA1 calcium pump | Defects cause Brody myopathy |
| MYH7 | Myosin heavy chain | Mutations associated with myopathies |
| TNNT3 | Fast skeletal muscle troponin T | Regulates calcium sensitivity |
| MYBPC2 | Myosin-binding protein C | Modulates thick filament regulation |
| TTN | Titin, molecular spring | Provides passive tension and signaling |
| SCN4A | Voltage-gated sodium channel | Mutations cause periodic paralysis |
| CLCN1 | Chloride channel | Defects cause myotonia congenita |
| ATP1A2 | Na+/K+-ATPase | Maintains ion gradients for excitability |
| CACNB1 | DHPR auxiliary subunit | Modulates calcium channel function |
| CALM1 | Calmodulin | Regulates calcium signaling |
| TNNC2 | Fast troponin C | Calcium sensor for contraction |
| TPM1 | Tropomyosin | Regulates actin-myosin interaction |
| ACTN2 | Alpha-actinin-2 | Z-disc structural protein |
| MYL1 | Myosin light chain 1 | Modulates myosin function |
| MYL2 | Myosin light chain 2 | Regulatory light chain |
How Is regulation of skeletal muscle contraction by action potential Regulated?
The process of regulation of skeletal muscle contraction by action potential is modulated by several factors. Intracellular ATP levels are critical for both cross-bridge cycling and calcium reuptake, and metabolic pathways such as glycophagy help maintain energy supply during contraction. Additionally, myosin-binding protein C and titin provide thick filament-based regulation that fine-tunes force output. Electrolyte balance, particularly potassium and calcium, directly affects membrane excitability and contractile strength. Lactic acidosis can impair performance by affecting calcium handling and cross-bridge kinetics.
regulation of skeletal muscle contraction by action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RYR1 | Malignant hyperthermia | Knock-in mouse with RYR1 mutation |
| CACNA1S | Hypokalemic periodic paralysis | Point-mutation in CACNA1S in C2C12 cells |
| ATP2A1 | Brody myopathy | Knockout of ATP2A1 in primary myotubes |
| SCN4A | Hyperkalemic periodic paralysis | Overexpression of mutant SCN4A in HEK293 cells |
| CLCN1 | Myotonia congenita | Knockout of CLCN1 in zebrafish |
Malignant Hyperthermia and Periodic Paralysis
Mutations in RYR1 and CACNA1S lead to malignant hyperthermia, a life-threatening reaction to anesthetics, and periodic paralyses characterized by episodic weakness. These disorders directly result from dysregulated excitation-contraction coupling.
Muscle Fatigue and Metabolic Myopathies
Impaired action potential regulation contributes to muscle fatigue, especially during intense exercise when lactic acidosis and ATP depletion occur. Metabolic myopathies often involve defects in energy supply for calcium reuptake and cross-bridge cycling.
Age-Related Sarcopenia
Alterations in action potential propagation and calcium handling are implicated in sarcopenia, the loss of muscle mass and strength with aging. Targeting these pathways may offer therapeutic benefits.
From regulation of skeletal muscle contraction by action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RYR1 abolish calcium release? | RYR1 knockout in C2C12 myotubes |
| Does a specific point mutation in CACNA1S alter gating? | CACNA1S point-mutation knock-in in mouse |
| Can overexpression of SERCA improve relaxation? | ATP2A1 overexpression in skeletal muscle cells |
| How does MYBPC2 tagging affect contraction? | Tagged knock-in of MYBPC2 in zebrafish |
| What is the role of TTN in passive tension? | TTN knockout in induced pluripotent stem cell-derived myotubes |
| Does mutant SCN4A cause hyperexcitability? | Overexpression of SCN4A mutant in Xenopus oocytes |
How to Study the regulation of skeletal muscle contraction by action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Ion channel currents and action potentials | Assessing excitability in muscle fibers |
| Calcium imaging | Intracellular calcium transients | Monitoring release and reuptake |
| Force transducer | Muscle contractile force | Evaluating contractile performance |
| RNA-seq | Gene expression profiles | Identifying dysregulated pathways |
| Proteomics | Protein abundance and modifications | Detecting changes in contractile proteins |
| CRISPR screening | Gene function at scale | Discovering novel regulators |
| Bioinformatics | Pathway enrichment and networks | Integrating multi-omics data |
Electrophysiology
Patch-clamp and voltage-clamp techniques measure action potential properties and ion channel currents in muscle fibers, providing direct assessment of excitability.
Calcium Imaging
Fluorescent calcium indicators (e.g., Fura-2) allow real-time visualization of calcium transients during excitation-contraction coupling in isolated muscle fibers.
Force Measurements
Isometric force transducers quantify contractile strength and kinetics in response to electrical stimulation, revealing deficits in contraction regulation.
Genomic and Proteomic Profiling
RNA-seq and proteomics identify expression changes in genes related to action potential regulation under conditions like fatigue or disease.
How CRISPR Can Be Used to Study GO:0100001 regulation of skeletal muscle contraction by action potential
Knockout
CRISPR knockout of genes such as RYR1 or ATP2A1 in skeletal muscle cell lines (e.g., C2C12) can abolish calcium release or reuptake, providing causal evidence for their roles in GO:0100001.
Point Mutation
Introducing disease-associated point mutations (e.g., in CACNA1S or SCN4A) via CRISPR base editing or HDR allows precise modeling of channelopathies affecting action potential regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into MYBPC2 or TTN enables live-cell imaging of thick filament dynamics during contraction.
Overexpression
Overexpression of SERCA1 (ATP2A1) or mutant SCN4A using CRISPR activation or lentiviral delivery can enhance relaxation or induce hyperexcitability, respectively.
How EDITGENE Supports regulation of skeletal muscle contraction by action potential Research
Researchers studying regulation of skeletal muscle contraction by action potential-related genes often need to determine whether a candidate gene is causally involved in excitation-contraction coupling or whether its mutation drives disease. EDITGENE provides tailored CRISPR solutions to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of skeletal muscle contraction by action potential research.
Frequently Asked Questions About regulation of skeletal muscle contraction by action potential
What is GO:0100001?
GO:0100001 is a Gene Ontology term for the biological process 'regulation of skeletal muscle contraction by action potential', which describes how electrical signals control muscle contraction.
What genes are involved in regulation of skeletal muscle contraction by action potential?
Key genes include RYR1, CACNA1S, ATP2A1, MYH7, TNNT3, and MYBPC2, among others.
How does action potential regulate skeletal muscle contraction?
Action potentials depolarize the T-tubules, triggering calcium release from the sarcoplasmic reticulum via RYR1, which then activates cross-bridge cycling.
What diseases are associated with defects in this process?
Malignant hyperthermia, periodic paralyses, Brody myopathy, and age-related sarcopenia are linked to dysregulation of this process.
What experimental models are used to study GO:0100001?
Common models include C2C12 myotubes, primary muscle fibers, and CRISPR-engineered mouse lines with mutations in RYR1 or CACNA1S.
How can CRISPR help study regulation of skeletal muscle contraction by action potential?
CRISPR enables knockout, point mutation, knock-in, and overexpression of genes like RYR1 and ATP2A1 to dissect their roles in contraction.
What is the role of calcium in this process?
Calcium released from the sarcoplasmic reticulum binds troponin C, moving tropomyosin to expose myosin-binding sites on actin, initiating contraction.
How is muscle relaxation achieved?
SERCA pumps calcium back into the sarcoplasmic reticulum, reducing cytosolic calcium and allowing muscle relaxation.
What is the role of ATP in regulation of skeletal muscle contraction by action potential?
ATP is required for both cross-bridge cycling and calcium reuptake by SERCA; energy depletion leads to fatigue.
Can electrolyte imbalances affect this process?
Yes, imbalances in potassium and calcium can alter membrane excitability and contractile strength, contributing to muscle disorders.
Conclusion
GO:0100001, regulation of skeletal muscle contraction by action potential, is a central biological process that couples electrical excitation to mechanical force in skeletal muscle. Its molecular players, including RYR1, CACNA1S, and ATP2A1, are critical for normal movement and are implicated in various myopathies and fatigue syndromes. Advanced CRISPR models and multi-omics approaches continue to unravel the complexities of this process, offering hope for targeted therapies. EDITGENE stands ready to support researchers with custom CRISPR solutions to accelerate discoveries in muscle physiology.
References
- 1. Cairns SP et al.. 2025. Lactic acidosis: implications for human exercise performance.. Eur J Appl Physiol 125(7):1761-1795 PMID: 40088272
- 2. Irving M. 2017. Regulation of Contraction by the Thick Filaments in Skeletal Muscle.. Biophys J 113(12):2579-2594 PMID: 29262355
- 3. Shrimanker I et al.. 2026. Electrolytes.. PMID: 31082167
- 4. Rhana P et al.. 2024. Fueling the heartbeat: Dynamic regulation of intracellular ATP during excitation-contraction coupling in ventricular myocytes.. Proc Natl Acad Sci U S A 121(25):e2318535121 PMID: 38865270
- 5. Heden TD et al.. 2022. Regulation and role of glycophagy in skeletal muscle energy metabolism.. Autophagy 18(5):1078-1089 PMID: 34506219
- 6. Sah R et al.. 2003. Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)).. J Physiol 546(Pt 1):5-18 PMID: 12509475
- 7. Tibbits GF et al.. 1991. Regulation of myocardial contractility.. Med Sci Sports Exerc 23(10):1140-4 PMID: 1661829
- 8. Hill C et al.. 2021. Myosin-based regulation of twitch and tetanic contractions in mammalian skeletal muscle.. Elife 10 PMID: 34121660
